Gray matter atrophy in patients with ischemic stroke with cognitive impairment

Glenn T Stebbins1, David L Nyenhuis, Changsheng Wang

  • 1Department of Neurological Sciences, Rush University Medical Center, 1725 W. Harrison, Suite 309, Chicago, IL 60612, USA. gstebbin@rush.edu

Stroke
|February 9, 2008
PubMed
Abstract

Insights

Patients with ischemic stroke may develop cognitive impairment. This study found reduced gray matter volume, particularly in the thalamus, in stroke patients with cognitive impairment, aiding in classification.

Area of Science:

  • Neuroscience
  • Radiology
  • Cognitive Neurology

Background:

  • Ischemic stroke patients face risks for vascular cognitive impairment (VCI), ranging from mild deficits to dementia.
  • Previous research implicated MRI findings like infarction, white matter hyperintensities, and cerebral atrophy in VCI development.

Purpose of the Study:

  • To investigate regional gray matter volume differences in patients with ischemic stroke.
  • To compare cognitive function between ischemic stroke patients without cognitive impairment and those with impairment in at least one cognitive domain.

Main Methods:

  • Ninety-one ischemic stroke patients underwent detailed neuropsychological testing across seven cognitive domains.
  • High-resolution structural MRI (3D fast-spoiled gradient recalled) was analyzed using voxel-based morphometry (VBM), controlling for stroke lesions.
  • Voxelwise regional gray matter volume differences were assessed between cognitively unimpaired and impaired stroke patient groups; logistic regression analyzed classification contributions.

Main Results:

  • Forty out of 91 patients exhibited cognitive impairment in at least one domain.
  • VBM revealed significant gray matter volume reductions in impaired patients, primarily in the thalamus, with smaller reductions in the cingulate gyrus and lobes.
  • Thalamic volume, derived from VBM, significantly improved the prediction of cognitive impairment group membership when added to demographic, stroke, and cognitive performance data.

Conclusions:

  • The thalamus plays a central role, and other cortical regions play lesser roles in cognitive impairment post-ischemic stroke.
  • Thalamic volume measurements provide significant additional information for classifying cognitive impairment in stroke patients beyond traditional measures.

Related Concept Videos

Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Ischemic Stroke ll: Pathophysiology01:15

Ischemic Stroke ll: Pathophysiology

An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Ischemic Stroke l: Introduction01:15

Ischemic Stroke l: Introduction

Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...